Skip to content

Clinical trials

Expanded access trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Expanded access Country / region: Netherlands Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available9
Approved for marketing7
Available2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer3
Bayer2
Novartis Pharmaceuticals2
Nuvalent Inc.2
Tibotec Pharmaceuticals, Ireland2
BioMarin Pharmaceutical1
Bristol-Myers Squibb1
Eisai Inc.1
Eli Lilly and Company1
Gilead Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung2
Breast Neoplasms1
COVID-191
Carcinoma, Renal Cell1
Colorectal Neoplasms1
Cystitis1
Dermatitis, Atopic1
Eczema1
Gastrointestinal Neoplasms1
HIV Infections1

Trials

Showing 76 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.